Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
5 results loaded, newest first. End of these results.
Option Care Health shares jumped 33% to $31.07 after McKesson and Clayton Dubilier & Rice agreed to buy the company in a deal valued at about $5.8 billion including debt. Shareholders will receive $32.05 per share, a 37.1% premium. McKesson will take a 49% stake.
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to buy infusion therapy provider Option Care Health for about $5.8 billion including debt.
CD&R and McKesson agreed to acquire Option Care Health for USD 32.05 per share, valuing the business at about USD 5.8 billion. CD&R will own about 51% at closing; McKesson will invest about USD 1.4 billion for about 49%. The deal implies a roughly 37% premium to Option Care Health’s Oct. 5, 2026 close.
The deal values Option Care Health at about $5.8 billion enterprise value. CD&R will hold about 51% at close and McKesson will invest about $1.4 billion for about 49%. Closing is targeted for the first half of calendar 2027, with Option Care Health shares delisted and made privately held.
CD&R and McKesson have agreed to acquire Option Care Health for $32.05 per share, valuing the company at approximately $5.8 billion. CD&R will hold about 51% at closing, while McKesson will invest about $1.4 billion for approximately 49%. The deal is expected to close in the first half of 2027, and Option Care Health s